News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 754 results

Oxford University startup ordered to pay royalties

UK05-01-2023Staff Writer

‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.

Amgen seals $28m deal for biotech

Ireland, US13-12-2022Staff Writer

Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi.

Voluntary licensing opens up HIV treatment to 100 countries

Belarus, Switzerland06-12-2022Staff Writer

Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees.

Pharma owners warned of Brexit effect on TMs

UK22-11-2022Muireann Bolger

Large market for parallel or ‘grey’ imports of pharmaceuticals due to pricing differences in various countries | Govt consultation respondents unhappy with ‘lack of EU reciprocity’| Mewburn Ellis.

Patent firms unveil joint UPC ‘powerhouse’

EU15-11-2022Muireann Bolger

Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.

In conversation with...Beatriz San Martin, Arnold & Porter

EU13-10-2022Sarah Speight

The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of.

Teva breached antitrust rules over Copaxone, says EU

EU11-10-2022Sarah Speight

European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be found to have infringed Article 102 of TFEU.

Bio-Techne takes patent dispute to UK

UK27-09-2022Staff Writer

The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.

EMA backs switch to biosimilars

EU22-09-2022Muireann Bolger

Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.

Swiss watchdog investigates Novartis over patent use

Switzerland20-09-2022Staff Writer

Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition

Showing 1 to 10 of 754 results

LSIPR